Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia
Katsiki, N.; Athyros, V.G.; Karagiannis, A.; Mikhailidis, D.P.
International Angiology a Journal of the International Union of Angiology 30(3): 295; Author Reply 296
2011
ISSN/ISBN: 0392-9590 PMID: 21617615 Document Number: 651425
Document emailed within 1 workday
Related Documents
Suzuki, H.; Inoue, T.; Watanabe, Y.; Kikuta, T.; Sato, T.; Tsuda, M. 2010: Efficacy and safety of ezetimibe and low-dose simvastatin as primary treatment for dyslipidemia in peritoneal dialysis patients Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 26: 53-57Riesen, W.F.; Keller, U.; Del Bufalo, A.; Reutter, F.W.; Baur, H.R.; Golay, A.; Bertel, O.; Kummer, H.; Kistler, H.; Ammann, F. 1989: Swiss simvastatin multicenter study: 1. Efficacy of 10 mg simvastatin daily in patients with primary hypercholesterolemia Schweizerische Medizinische Wochenschrift 119(48): 1719-1723
Martínez-Abundis, E.; Barrera-Durán, C.; González-Ortiz, M.; Hernández-Salazar, E. 2016: Effect of simvastatin plus inulin in comparison with simvastatin plus ezetimibe on the treatment of mixed dyslipidemia Gaceta Medica de Mexico 152(Suppl 2): 88-95
McKenney, J.; Ballantyne, C.M.; Feldman, T.A.; Brady, W.E.; Shah, A.; Davies, M.J.; Palmisano, J.; Mitchel, Y.B. 2005: LDL-C goal attainment with ezetimibe plus simvastatin coadministration vs atorvastatin or simvastatin monotherapy in patients at high risk of CHD Medgenmed: Medscape General Medicine 7(3): 3
Bo, M.; Nicolello, M.T.; Fiandra, U.; Mercadante, G.; Piliego, T.; Fabris, F. 2001: Treatment of heterozygous familial hypercholesterolemia: atorvastatin vs simvastatin Nutrition Metabolism and Cardiovascular Diseases: Nmcd 11(1): 17-24
Ali, A.; Martin, J.M. 2010: Hair growth in patients alopecia areata totalis after treatment with simvastatin and ezetimibe Journal of Drugs in Dermatology: Jdd 9(1): 62-64
Lambrecht, L.J.; Malini, P.L. 1993: Efficacy and tolerability of simvastatin 20 mg vs pravastatin 20 mg in patients with primary hypercholesterolemia. European Study Group Acta Cardiologica 48(6): 541-554
Vorob'eva, N.M.; Panchenko, E.P.; Dobrovol'skiĭ, A.B.; Titaeva, E.V.; Ermolina, O.V.; Balakhonova, T.V.; Khasanova, Z.B.; Postnov, A.I.; Kirienko, A.I. 2011: Thrombin-activated inhibitor of fibrinolysis and efficacy and safety of long-term warfarin treatment in patients with venous thromboembolic complications Terapevticheskii Arkhiv 83(12): 43-48
Stefanutti, C.; Lucani, G.; Vivenzio, A.; Di Giacomo, S. 1999: Diet only and diet plus simvastatin in the treatment of heterozygous familial hypercholesterolemia in childhood Drugs under Experimental and Clinical Research 25(1): 23-28
Tomei, R.; Rossi, L.; Carbonieri, E.; Franceschini, L.; Cemin, C.; Ghebremariam-Tesfau, K.; Zardini, P. 1993: Efficacy and tolerability of simvastatin and omega-3 fatty acid combination in patients with coronary disease, hypercholesterolemia and hypertriglyceridemia Cardiologia 38(12): 773-778
Leclercq, V.; Harvengt, C. 1989: Simvastatin (MK 733) in heterozygous familial hypercholesterolemia: a two-year trial International Journal of Clinical Pharmacology Therapy and Toxicology 27(2): 76-81
Miki, T. 2017: Efficacy and safety of long-term bisphosphonate treatment for osteoporosis Clinical Calcium 27(2): 239-246
Stein, E.; Kreisberg, R.; Miller, V.; Mantell, G.; Washington, L.; Shapiro, D.R. 1990: Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group i Archives of Internal Medicine 150(2): 341-345
Lucky, A.W.; Maloney, J.M.; Roberts, J.; Taylor, S.; Jones, T.; Ling, M.; Garrett, S. 2007: Dapsone gel 5% for the treatment of acne vulgaris: safety and efficacy of long-term (1 year) treatment Journal of Drugs in Dermatology: Jdd 6(10): 981-987
Saku, K.; Takeda, Y.; Shirai, K.; Nii, T.; Ohta, T.; Arakawa, K. 1997: Long-term follow-up by coronary angiography in a patient with heterozygous familial hypercholesterolemia: a case report Journal of Cardiology 30(3): 137-142
Myburgh, D.P. 1990: Long-term efficacy and safety of sustained-release diltiazem in the treatment of hypertension South African Medical Journal 78(8): 456-457
Giannini, S.D.; de Góes, J.M.; Dereviack, B.E.; Machado, C.; Forti, N.; Diament, J. 1990: Simvastatin (MK-733), a new HMG-CoA reductase inhibitor, in the treatment of hypercholesterolemia in elderly patients with atherosclerosis Arquivos Brasileiros de Cardiologia 54(6): 407-414
Fricker, J.; Douste-Blazy, P.; Drouin, P.; De Gennes, J.L.; Dachet, C.; Keller, U. 1990: The efficacy and tolerance of simvastatin and fenofibrate in primary hypercholesterolemia Presse Medicale 19(42): 1927-1930
Shmidt, E.I.; Bilinskaia, M.A.; Belozerova, I.V.; Soldatov, D.G.; Dmitrieva, M.E. 2007: Long-term efficacy and safety of chondroitin sulphate (structum, France) in patients with coxarthrosis Terapevticheskii Arkhiv 79(1): 65-67
Omvik, P.; Thaulow, E.; Herland, O.B.; Eide, I.; Midha, R.; Turner, R.R. 1993: A double-blind, long-term, comparative study on quality of life, safety, and efficacy during treatment with amlodipine or enalapril in mild or moderate hypertensive patients: a multicenter study Journal of Cardiovascular Pharmacology 22 Suppl A: S13-S19